Moderna’s Earnings, Revenue Fall on Fewer Covid Vaccine Sales
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
The retooled Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4...
U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron, in preparation for a...
Pfizer Inc. and BioNTech SE vaccines modified to target the Omicron variant produced a significantly larger immune response than the...
A positive recommendation would likely lead soon to expanding the U.S. Covid-19 vaccination campaign to the 19.6 million children 6...
The FDA staff also said, in a review of study data posted online Sunday, that there were no new safety...
The Centers for Disease Control and Prevention recommended Covid-19 boosters for 12- to 15-year-olds, making the doses available to the...
LONDON— AstraZeneca PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have...
U.S. vaccine advisers are meeting to consider whether to change recommendations on the use of Johnson & Johnson ’s Covid-19...
Human blood samples and the substance that makes fireflies glow are among the tools that scientists are using for early...
The Food and Drug Administration on Friday cleared Covid-19 boosters from Pfizer Inc. and BioNTech SE and from Moderna Inc....
Pfizer Inc. said a preliminary look at study results found that its experimental pill was highly effective at preventing people...
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
Johnson & Johnson said Wednesday that a second dose of its Covid-19 vaccine was found in a study to generate...
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...
The U.S. has purchased 200 million additional Covid-19 vaccine doses from Pfizer Inc. PFE 0.51% and partner BioNTech SE, BNTX...